A 12 months course of interferon and lamivudine combination therapy versus interferon monotherapy for untreated chronic hepatitis B infection

dc.contributor.authorYalcin, K
dc.contributor.authorYildiz, F
dc.contributor.authorDegertekin, H
dc.contributor.authorCelik, Y
dc.date.accessioned2024-04-24T16:18:47Z
dc.date.available2024-04-24T16:18:47Z
dc.date.issued2002
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1016/S0168-8278(02)80494-9
dc.identifier.endpage138en_US
dc.identifier.issn0168-8278
dc.identifier.startpage138en_US
dc.identifier.urihttps://doi.org/10.1016/S0168-8278(02)80494-9
dc.identifier.urihttps://hdl.handle.net/11468/16282
dc.identifier.volume36en_US
dc.identifier.wosWOS:000175704700490
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofJournal of Hepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleA 12 months course of interferon and lamivudine combination therapy versus interferon monotherapy for untreated chronic hepatitis B infectionen_US
dc.titleA 12 months course of interferon and lamivudine combination therapy versus interferon monotherapy for untreated chronic hepatitis B infection
dc.typeConference Objecten_US

Dosyalar